SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-254034
Filing Date
2021-08-23
Accepted
2021-08-23 16:35:37
Documents
4
Effectiveness Date
2021-08-23

Document Format Files

Seq Description Document Type Size
1 S-8 d214368ds8.htm S-8 71279
2 EX-5.1 d214368dex51.htm EX-5.1 7583
3 EX-23.1 d214368dex231.htm EX-23.1 1671
4 GRAPHIC g214368g74e69.jpg GRAPHIC 3818
  Complete submission text file 0001193125-21-254034.txt   86963
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259008 | Film No.: 211197411
SIC: 2836 Biological Products, (No Diagnostic Substances)